Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2013/147135
Kind Code:
A1
Abstract:
Provided is a controlled-release pharmaceutical composition which contains 4-{[(1R,2s,3S,5s,7s)-5-hydroxy-2-adamantyl]- amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide, which is a compound of which the solubility in an acidic pH region is extremely different from that in a neutral pH region, as a medicinal agent, wherein the solubility of the medicinal agent can be maintained in a neutral pH region in the digestive tract after gastric emptying (e.g., the small intestine) and the controlled-release pharmaceutical composition exhibits a good oral absorption property and has high bioavailability. The controlled-release pharmaceutical composition comprises 4-{[(1R,2s,3S,5s,7s)-5-hydroxy-2-adamantyl]amino}-1H- pyrrolo[2,3-b]pyridine-5-carboxamide or a pharmaceutically acceptable salt thereof, an acidic substance, a persaturation-maintaining agent, and a controlled-release base ingredient.

Inventors:
KOJIMA HIROYUKI (JP)
TAKAE SEIJI (JP)
YASUJI TAKEHIKO (JP)
SAKURAI ATSUSHI (JP)
IKEUCHI SATOMI (JP)
SAKO KAZUHIRO (JP)
Application Number:
PCT/JP2013/059487
Publication Date:
October 03, 2013
Filing Date:
March 29, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ASTELLAS PHARMA INC (JP)
International Classes:
A61K31/437; A61K9/14; A61K9/16; A61K9/20; A61K9/48; A61K47/12; A61K47/32; A61K47/34; A61K47/38; A61P9/10; A61P11/06; A61P17/00; A61P25/28; A61P35/00; A61P35/02; A61P37/06; A61P37/08; A61P43/00; C07D471/04
Domestic Patent References:
WO1994006414A11994-03-31
WO2010038690A12010-04-08
Foreign References:
JP2009522206A2009-06-11
JP2004518676A2004-06-24
JP2009504796A2009-02-05
JPS62242615A1987-10-23
Attorney, Agent or Firm:
MORITA Kenichi et al. (JP)
Ken-ichi Morita (JP)
Download PDF: